{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:46:10Z","timestamp":1786488370254,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1124\/jpet.121.001020","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T11:35:13Z","timestamp":1649504113000},"page":"257-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-\u03b2\/Smad Signaling in an Animal Model of Biliary Atresia"],"prefix":"10.1016","volume":"381","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6796-3774","authenticated-orcid":false,"given":"Jian-Li","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8679-5494","authenticated-orcid":false,"given":"Guo-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7495-0741","authenticated-orcid":false,"given":"Yu-Na","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7122-2266","authenticated-orcid":false,"given":"Xiao-Yan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8239-4848","authenticated-orcid":false,"given":"Hai-Tao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4244-805X","authenticated-orcid":false,"given":"Xiang-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6490-0855","authenticated-orcid":false,"given":"Fei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8155-7190","authenticated-orcid":false,"given":"Ling-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.001020_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrgastro.2015.74","article-title":"Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes","volume":"12","author":"Asai","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1124\/jpet.121.001020_bib2","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.21037\/apm-20-288","article-title":"Ligustrazine induces the colorectal cancer cells apoptosis via p53-dependent mitochondrial pathway and cell cycle arrest at the G0\/G1 phase","volume":"10","author":"Bian","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1124\/jpet.121.001020_bib3","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/hep.26161","article-title":"Adult sea lamprey tolerates biliary atresia by altering bile salt composition and renal excretion","volume":"57","author":"Cai","year":"2013","journal-title":"Hepatology"},{"key":"10.1124\/jpet.121.001020_bib4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1124\/jpet.121.001020_bib5","doi-asserted-by":"crossref","first-page":"e2719","DOI":"10.1038\/cddis.2017.99","article-title":"Forkhead box A3 attenuated the progression of fibrosis in a rat model of biliary atresia","volume":"8","author":"Dong","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1124\/jpet.121.001020_bib6","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/gutjnl-2019-319091","article-title":"TGF-\u03b22 silencing to target biliary-derived liver diseases","volume":"69","author":"Dropmann","year":"2020","journal-title":"Gut"},{"key":"10.1124\/jpet.121.001020_bib7","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/hep.510240539","article-title":"Retrograde injections of formaldehyde into the biliary tree induce alterations of biliary epithelial function in rats","volume":"24","author":"Dumont","year":"1996","journal-title":"Hepatology"},{"key":"10.1124\/jpet.121.001020_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fonc.2018.00357","article-title":"Transforming growth factor-\u03b2-induced cell plasticity in liver fibrosis and hepatocarcinogenesis","volume":"8","author":"Fabregat","year":"2018","journal-title":"Front Oncol"},{"key":"10.1124\/jpet.121.001020_bib9","first-page":"50","article-title":"Injection of ethanol into the common bile duct to establish a rat model of biliary atresia","author":"Ge","year":"2014","journal-title":"Acta Laboratorium Animalis Scientia Sinica"},{"key":"10.1124\/jpet.121.001020_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.678530","article-title":"Rationale for the use of pirfenidone in heart failure with preserved ejection fraction","volume":"8","author":"Graziani","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1124\/jpet.121.001020_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8846708","article-title":"Pirfenidone alleviates choroidal neovascular fibrosis through the TGF-\u03b2\/Smad signaling pathway","volume":"2021","author":"Gao","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1124\/jpet.121.001020_bib12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.4254\/wjh.v8.i36.1593","article-title":"Biliary atresia: where do we stand now?","volume":"8","author":"Govindarajan","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1124\/jpet.121.001020_bib13","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u03b2 signaling from receptors to Smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/jpet.121.001020_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1751-0813.1990.tb07385.x","article-title":"Congenital biliary atresia and jaundice in lambs and calves","volume":"67","author":"Harper","year":"1990","journal-title":"Aust Vet J"},{"key":"10.1124\/jpet.121.001020_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13020-018-0194-9","article-title":"Combination of Salvia miltiorrhiza and ligustrazine attenuates bleomycin-induced pulmonary fibrosis in rats via modulating TNF-\u03b1 and TGF-\u03b2","volume":"13","author":"Huang","year":"2018","journal-title":"Chin Med"},{"key":"10.1124\/jpet.121.001020_bib16","first-page":"1069","article-title":"Conversion of equivalent doses between animals and between animals and humans in pharmacological tests [in Chinese]","volume":"9","author":"Huang","year":"2004","journal-title":"Chinese J Pharmacol Toxicol"},{"key":"10.1124\/jpet.121.001020_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep44754","article-title":"Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis","volume":"7","author":"Komiya","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.121.001020_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/13543776.2021.1896705","article-title":"Targeting the TGF-\u03b2 signaling pathway for fibrosis therapy: a patent review (2015-2020)","volume":"31","author":"Li","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/jpet.121.001020_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tox.2016.07.018","article-title":"Nrf2 knockdown attenuates the ameliorative effects of ligustrazine on hepatic fibrosis by targeting hepatic stellate cell transdifferentiation","volume":"365","author":"Lu","year":"2016","journal-title":"Toxicology"},{"key":"10.1124\/jpet.121.001020_bib20","doi-asserted-by":"crossref","first-page":"40468","DOI":"10.1038\/srep40468","article-title":"MircoRNA-145 promotes activation of hepatic stellate cells via targeting kr\u00fcppel-like factor 4","volume":"7","author":"Men","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.121.001020_bib21","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1242\/jcs.114.24.4359","article-title":"Smad regulation in TGF-beta signal transduction","volume":"114","author":"Moustakas","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1124\/jpet.121.001020_bib22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/jpet.121.001020_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12072-020-10069-3","article-title":"Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study","volume":"14","author":"Poo","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1124\/jpet.121.001020_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4103\/0973-1482.147378","article-title":"Ligustrazine induces apoptosis of breast cancer cells in vitro and in vivo","volume":"11","author":"Pan","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"10.1124\/jpet.121.001020_bib25","article-title":"A review of pirfenidone as an anti-fibrotic in idiopathic pulmonary fibrosis and its probable role in other diseases","volume":"13","author":"Shah","year":"2021","journal-title":"Cureus"},{"key":"10.1124\/jpet.121.001020_bib26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.bbrc.2019.11.040","article-title":"miR-145-5p attenuates hypertrophic scar via reducing Smad2\/Smad3 expression","volume":"521","author":"Shen","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.121.001020_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MPG.0000000000002582","article-title":"Direct health care costs, health services utilization, and outcomes of biliary atresia: a population-based cohort study","volume":"70","author":"Siddiq","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1124\/jpet.121.001020_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00595-012-0379-2","article-title":"Intrahepatic biliary ablation with pure ethanol: an experimental model of biliary atresia","volume":"43","author":"Tatekawa","year":"2013","journal-title":"Surg Today"},{"key":"10.1124\/jpet.121.001020_bib29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1681\/ASN.2012101041","article-title":"Kindlin-2 mediates activation of TGF-\u03b2\/Smad signaling and renal fibrosis","volume":"24","author":"Wei","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.121.001020_bib30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.23812\/19-27-A","article-title":"The role of miR-145 in promoting the fibrosis of pulmonary fibroblasts","volume":"33","author":"Xu","year":"2019","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1124\/jpet.121.001020_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-\u03b2\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/jpet.121.001020_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ptr.3630","article-title":"Effects of ligustrazine on ureteral obstruction-induced renal tubulointerstitial fibrosis","volume":"26","author":"Yuan","year":"2012","journal-title":"Phytother Res"},{"key":"10.1124\/jpet.121.001020_bib33","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1016\/j.febslet.2012.06.048","article-title":"MicroRNA-145 suppresses mouse granulosa cell proliferation by targeting activin receptor IB","volume":"586","author":"Yan","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.121.001020_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180896","article-title":"Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3","volume":"12","author":"Ye","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/jpet.121.001020_bib35","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1096\/fj.12-219493","article-title":"miR-145 regulates myofibroblast differentiation and lung fibrosis","volume":"27","author":"Yang","year":"2013","journal-title":"FASEB J"},{"key":"10.1124\/jpet.121.001020_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molimm.2016.05.018","article-title":"MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt\/\u03b2-catenin pathway","volume":"75","author":"Zhou","year":"2016","journal-title":"Mol Immunol"},{"key":"10.1124\/jpet.121.001020_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7150\/thno.22237","article-title":"Ligand activation of PPAR\u03b3 by ligustrazine suppresses pericyte functions of hepatic stellate cells via SMRT-mediated transrepression of HIF-1\u03b1","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"10.1124\/jpet.121.001020_bib38","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/febs.12818","article-title":"Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor \u03b2 receptor pathways","volume":"281","author":"Zhang","year":"2014","journal-title":"FEBS J"},{"key":"10.1124\/jpet.121.001020_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2012.09.016","article-title":"Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-\u03b2 receptor-mediated ERK and p38 pathways","volume":"265","author":"Zhang","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.121.001020_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCRESAHA.115.303970","article-title":"MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells","volume":"116","author":"Zhao","year":"2015","journal-title":"Circ Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.001020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:26:29Z","timestamp":1739971589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524002817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0022356524002817"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.001020","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-\u03b2\/Smad Signaling in an Animal Model of Biliary Atresia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.001020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}